Involvement of α7 nicotinic acetylcholine receptors in gene expression of dopamine biosynthetic enzymes in rat brain

Journal of Pharmacology and Experimental Therapeutics

Volumn 303, Issue 3, 2002, Pages 896-903

  Serova, Lidia ^a   Sabban, Esther L ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2,4 DIMETHOXYBENZILIDENE)ANABASEINE; ANABASINE DERIVATIVE; GST 21; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; MESSENGER RNA; METHYLLYCACONITINE; NICOTINE; NICOTINIC RECEPTOR; TETRAHYDROBIOPTERIN; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BODY WEIGHT; BRAIN; CARDIOVASCULAR SYSTEM; CATECHOLAMINERGIC SYSTEM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; GENE EXPRESSION; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GTP CYCLOHYDROLASE; MALE; NICOTINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; RNA, MESSENGER; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 0036897380     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.039198     Document Type: Article

References (40)

1. Benowitz NL (1990) Clinical pharmacology of inhaled drugs of abuse: Implications in understanding nicotine dependence. NIDA Res Monogr 99:12-29.
2. Broide RS and Leslie FM (1999) The α7 nicotinic acetylcholine receptor in neuronal plasticity. Mol Neurobiol 20:1-16.
3. Court JA, Piggott MA, Lloyd S, Cookson N, Ballard CG, McKeith IG, Perry RH, and Perry EK (2000) Nicotine binding in human striatum: Elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Neuroscience 98:79-87.
4. Fossom LH, Sterling C, and Tank AW (1991) Activation of tyrosine hydroxylase by nicotine in rat adrenal gland. J Neurochem 57:2070-2077.
5. George TP, Verrico CD, Picciotto MR, and Roth RH (2000a) Nicotinic modulation of mesoprefrontal dopamine neurons: Pharmacologic and neuroanatomic characterization. J Pharmacol Exp Ther 295:58-66.
6. George TP, Verrico CD, Xu L, and Roth RH (2000b) Effects of repeated nicotine administration and footshock stress on rat mesoprefrontal dopamine systems: Evidence for opioid mechanisms. Neuropsychopharmacology 23:79-88.
7. Grottick AJ, Trube G, Corrigall WA, Huwyler J, Malherbe P, Wyler R, and Higgins GA (2000) Evidence that nicotinic α(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. J Pharmacol Exp Ther 294:1112-1119.
8. Gueorguiev VD, Zeman RJ, Meyer EM, and Sabban EL (2000) Involvement of α7 nicotinic acetylcholine receptors in activation of tyrosine hydroxylase and dopamine β-hydroxylase gene expression in PC12 cells. J Neurochem 75:1997-2005.
9. Hirayama K and Kapatos G (1998) Nigrostriatal dopamine neurons express low levels of GTP cyclohydrolase I protein. J Neurochem 70:164-170.
10. Hiremagalur B and Sabban EL (1995) Nicotine elicits changes in expression of adrenal catecholamine biosynthetic enzymes, neuropeptide Y and immediate early genes by injection but not continuous administration. Brain Res Mol Brain Res 32:109-115.
11. Hofle G, Weiler R, Fischer-Colbrie R, Humpel C, Laslop A, Wohlfarter T, Hogue-Angeletti R, Saria A, Fleming PJ, and Winkler H (1991) Stimulation of rat adrenal medulla can induce differential changes in the peptide and mRNA levels of chromogranins, neuropeptides and other constituents of chromaffin granules. Regul Pept 32:321-331.
12. Jonnala RR and Buccafusco JJ (2001) Relationship between the increased cell surface α7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists. J Neurosci Res 66:565-572.
13. Kem WR (2000) The brain α7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: Studies with DMXBA (GTS-21). Behav Brain Res 113:169-181.
14. Kettler R, Bartholini G, and Pletscher A (1974) In vivo enhancement of tyrosine hydroxylation in rat striatum by tetrahydrobiopterin. Nature (Lond) 249:476-478.
15. Leonard S and Bertrand D (2001) Neuronal nicotinic receptors: From structure to function. Nicotine Tob Res 3:203-223.
16. Li Y, King MA, Grimes J, Smith N, de Fiebre CM, and Meyer EM (1999) α7 nicotinic receptor mediated protection against ethanol-induced cytotoxicity in PC12 cells. Brain Res 816:225-228.
17. Machu TK, Hamilton ME, Frye TF, Shanklin CL, Harris MC, Sun H, Tenner TE Jr, Soti FS, and Kem WR (2001) Benzylidene analogs of anabaseine display partial agonist and antagonist properties at the mouse 5-hydroxytryptamine(3A) receptor. J Pharmacol Exp Ther 299:1112-1119.
18. Meyer EM, King MA, and Meyers C (1998) Neuroprotective effects of 2,4-dimethoxybenzylidene anabaseine (DMXB) and tetrahydroaminoacridine (THA) in neocortices of nucleus basalis lesioned rats. Brain Res 786:252-254.
19. Meyer EM, Tay ET, Papke RL, Meyers C, Huang GL, and de Fiebre CM (1997) 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat α7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner. Brain Res 768:49-56.
20. Mitchell SN, Smith KM, Joseph MH, and Gray JA (1993) Increases in tyrosine hydroxylase messenger RNA in the locus coeruleus after a single dose of nicotine are followed by time-dependent increases in enzyme activity and noradrenaline release. Neuroscience 56:989-997.
21. Nagatsu T and Ichinose H (1999) Regulation of pteridine-requiring enzymes by the cofactor tetrahydrobiopterin. Mol Neurobiol 19:79-96.
22. Nakamura K, Bindokas VP, Kowlessur D, Elas M, Milstien S, Marks JD, Halpern HJ, and Kang UJ (2001) Tetrahydrobiopterin scavenges superoxide in dopaminergic neurons. J Biol Chem 276:34402-34407.
23. Nomikos GG, Hildebrand BE, Panagis G, and Svensson TH (1999) Nicotine withdrawal in the rat: Role of α7 nicotinic receptors in the ventral tegmental area. Neuroreport 10:697-702.
24. Panagis G, Kastellakis A, Spyraki C, and Nomikos G (2000) Effects of methyllycaconitine (MLA), an α7 nicotinic receptor antagonist, on nicotine- and cocaine-induced potentiation of brain stimulation reward. Psychopharmacology 149:388-396.
25. Pugh PC and Berg DK (1994) Neuronal acetylcholine receptors that bind α-bungarotoxin mediate neurite retraction in a calcium-dependent manner. J Neurosci 14:889-896.
26. Rusted JM, Newhouse PA, and Levin ED (2000) Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer's disease and Parkinson's disease. Behav Brain Res 113:121-129.
27. Schilstrom B, Svensson HM, Svensson TH, and Nomikos GG (1998) Nicotine and food induced dopamine release in the nucleus accumbens of the rat: Putative role of α7 nicotinic receptors in the ventral tegmental area. Neuroscience 85:1005-1009.
28. Serova L, Danailov E, Chamas F, and Sabban EL (1999a) Nicotine infusion modulates immobilization stress-triggered induction of gene expression of rat catecholamine biosynthetic enzymes. J Pharmacol Exp Ther 291:884-892.
29. Serova LI, Nankova BB, Feng Z, Hong JS, Hutt M, and Sabban EL (1999b) Heightened transcription for enzymes involved in norepinephrine biosynthesis in the rat locus coeruleus by immobilization stress. Biol Psychiatry 45:853-862.
30. Serova L, Nankova B, Rivkin M, Kvetnansky R, and Sabban EL (1997) Glucocorticoids elevate GTP cyclohydrolase I mRNA levels in vivo and in PC12 cells. Brain Res Mol Brain Res 48:251-258.
31. Serova LI and Sabban EL (2002) Estradiol modulates GTP cyclohydrolase I gene expression in brain catecholaminergic systems, in Chemistry and Biology of Pteridins and Folates (Milstien S, Kapatos G, Levine RA, and Shane B eds) pp 145-149, Kluwer Academic Publishers, Boston.
32. Shen Y, Muramatsu SI, Ikeguchi K, Fujimoto KI, Fan DS, Ogawa M, Mizukami H, Urabe M, Kume A, Nagatsu I, et al. (2000) Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L·amino acid decarboxylase and GTP cyclohydrolase I for gene therapy of Parkinson's disease. Hum Gene Ther 11:1509-1519.
33. Slotkin TA, Seidler FJ, Lau C, Bartolome J, and Schanberg SM (1976) Effects of chronic chlorisondamine administration on the sympatho-adrenal axis. Biochem Pharmacol 25:1311-1315.
34. Smith KM, Mitchell SN, and Joseph MH (1991) Effects of chronic and subchronic nicotine on tyrosine hydroxylase activity in noradrenergic and dopaminergic neurones in the rat brain. J Neurochem 57:1750-1756.
35. Stevens KE, Kem WR, Mahnir VM, and Freedman R (1998) Selective α7-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology 136:320-327.
36. Sumi-Ichinose C, Urano F, Kuroda R, Ohye T, Kojima M, Tazawa M, Shiraishi H, Hagino Y, Nagatsu T, Nomura T, et al. (2001) Catecholamines and serotonin are differently regulated by tetrahydrobiopterin. A study from 6-pyruvoyltetrahydropterin synthase knockout mice. J Biol Chem 276:41150-41160.
37. Tsai MJ and Lee EH (1995) Nicotine enhances brain biopterin concentration in rats. Neurochem Int 27:213-217.
38. Tsuneki H, Klink R, Lena C, Korn H, and Changeux JP (2000) Calcium mobilization elicited by two types of nicotinic acetylcholine receptors in mouse substantia nigra pars compacta. Eur J Neurosci 12:2475-2485.
39. Turek JW, Kang CH, Campbell JE, Arneric SP, and Sullivan JP (1995) A sensitive technique for the detection of the α7 neuronal nicotinic acetylcholine receptor antagonist, methyllycaconitine, in rat plasma and brain. J Neurosci Methods 61:113-118.
40. Zhu M, Hirayama K, and Kapatos G (1994) Regulation of tetrahydrobiopterin biosynthesis in cultured dopamine neurons by depolarization and cAMP. J Biol Chem 269:11825-11829.